User profiles for Chengjin Ye
 | Chengjin YeTexas Biomedical Research Institute Verified email at txbiomed.org Cited by 2339 |
Multi-objective optimal power flow considering transient stability based on parallel NSGA-II
CJ Ye, MX Huang - IEEE Transactions on Power Systems, 2014 - ieeexplore.ieee.org
Stability is an important constraint in power system operation and the transient stability
constrained optimal power flow (OPF) has always received considerable attention in recent years. …
constrained optimal power flow (OPF) has always received considerable attention in recent years. …
[HTML][HTML] SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein, including …
induced by previous infection or vaccination through mutations in the spike protein, including …
Rescue of SARS-CoV-2 from a single bacterial artificial chromosome
Infectious coronavirus (CoV) disease 2019 (COVID-19) emerged in the city of Wuhan (China)
in December 2019, causing a pandemic that has dramatically impacted public health and …
in December 2019, causing a pandemic that has dramatically impacted public health and …
[HTML][HTML] Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease
would benefit from validated small animal models. Here, we show that transgenic mice …
would benefit from validated small animal models. Here, we show that transgenic mice …
[HTML][HTML] Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
Due to differences in human and murine angiotensin converting enzyme 2 (ACE-2) receptor,
initially available SARS-CoV-2 isolates could not infect mice. Here we show that serial …
initially available SARS-CoV-2 isolates could not infect mice. Here we show that serial …
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
Vaccines and drugs have helped reduce disease severity and blunt the spread of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). However, ongoing virus transmission…
respiratory syndrome coronavirus 2 (SARS-CoV-2). However, ongoing virus transmission…
SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
…, F Costacurta, SA Moghadasi, C Ye… - Science translational …, 2022 - science.org
Protease inhibitors are among the most powerful antiviral drugs. Nirmatrelvir is the first
protease inhibitor specifically developed against the SARS-CoV-2 protease 3CL pro that has …
protease inhibitor specifically developed against the SARS-CoV-2 protease 3CL pro that has …
Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
current COVID-19 pandemic, is one of the biggest threats to public health. However, the …
current COVID-19 pandemic, is one of the biggest threats to public health. However, the …
[PDF][PDF] SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming
How SARS-CoV-2 penetrates the airway barrier of mucus and periciliary mucins to infect
nasal epithelium remains unclear. Using primary nasal epithelial organoid cultures, we found …
nasal epithelium remains unclear. Using primary nasal epithelial organoid cultures, we found …
Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
pathogen responsible for coronavirus disease 2019 (COVID-19), has devastated public health …
pathogen responsible for coronavirus disease 2019 (COVID-19), has devastated public health …